文献速递产科

剖宫产术后限制性阿片类处方政策对门诊阿片类药物消耗及疼痛控制感知的影响

Post-cesarean delivery outpatient opioid consumption and perception of pain control following implementation of a restrictive opioid prescription protocol.
PubMed 文献 · Am J Obstet Gynecol MFM · 2019-09-27

本研究通过Plan-Do-Check-Act模型实施质量改进,2017年7月起禁止剖宫产出院时常规开具阿片类药物,患者可电话请求额外镇痛。对283名产妇出院后电话访谈显示,出院阿片类处方率从97.9%降至0%,出院后处方率18%,89%患者疼痛控制满意,90%仅需布洛芬或对乙酰氨基酚。

要点

  • 限制性政策使剖宫产出院阿片类处方率从97.9%降至0%。
  • 89%患者对疼痛控制满意,90%仅需非阿片类镇痛药。
  • 出院后18%患者获阿片类处方,其中仅51%实际服用。

核心结论

  • 实施限制性阿片类处方政策后,多数剖宫产产妇疼痛控制充分,患者满意度高,表明该政策可行。

研究设计与样本

  • 质量改进研究采用Plan-Do-Check-Act模型,2017年7月起实施限制性政策,2017年8月至2018年2月对283名英语产妇进行出院后电话访谈。

主要发现

  • 出院阿片类处方率从97.9%降至0%,出院后处方率18%。
  • 89%(n=253)患者出院时疼痛得到充分控制,90%(n=256)仅需布洛芬或对乙酰氨基酚。
  • 出院后获阿片类处方的51例中仅51%(n=27)服用,13%(n=37)希望出院时开具更强镇痛药。
  • 与出院后阿片类消耗相关的因素包括白种人、多产次及住院期间阿片类使用。

临床怎么用

  • 剖宫产术后可实施限制性阿片类处方政策,出院时默认不开阿片类药物,提供电话请求通道。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cesarean delivery is the most common laparotomy performed in the United States and can be the first exposure to opioids for many women. Unnecessary consumption of opioids may lead to long-term addiction and further perpetuate this national health crisis. OBJECTIVES: The primary objective of the study was to assess whether a quality improvement initiative by means of a restrictive opioid prescription policy decreases opioid consumption and maintains patient satisfaction after cesarean delivery. A secondary objective is to correlate opioid consumption with demographic and perioperative factors. MATERIALS AND METHODS: A Plan, Do, Check, Act model was used to implement a quality improvement initiative. A restrictive opioid prescribing policy was put in place in July 2017 preventing all physicians from prescribing opioids to their patients upon discharge after cesarean delivery; patients could call their providers from home to request additional analgesia (opioid or nonopioid) if pain was not sufficiently controlled. From August 2017 to February 2018, a postdischarge telephone interview assessing pain control satisfaction and opioid consumption was conducted for all English-speaking patients in our hospital who underwent a cesarean delivery. Statistical analysis was performed using IBM SPSS 22.0, with P < .05 reported as statistically significant. RESULTS: A total of 283 parturients were interviewed 8-33 days after cesarean delivery (mean, 16 days). After implementation of the restrictive opioid prescription policy, we observed a decrease in opioid prescriptions at discharge after cesarean delivery from 97.9% to 0%, with an 18% prescription rate after discharge. Patients reported high satisfaction with their pain control, with 89% (n = 253) stating that their pain was adequately controlled upon discharge. Although 90% (n = 256) reported that they did not need any pain medication other than ibuprofen or acetaminophen, opioids were prescribed to 18% of patients (n = 51) after discharge, with only 51% of these women (n = 27) consuming them. In response to the restrictive opioid prescribing policy, only 13% of the women (n = 37) reported that they wished that a stronger pain medication had been prescribed after hospital discharge. Factors associated with opioid consumption postdischarge included white race/ethnicity, multiparity, and opioid consumption during inpatient hospitalization. CONCLUSION: Following implementation of the restrictive opioid prescribing policy, most women experienced adequate pain control after cesarean delivery. Patient satisfaction with pain control was high, showing that it is feasible to implement restrictive opioid prescription policies while maintaining a high satisfaction rate.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Lakhi N, Tricorico G, Kanninen T, et al. Post-cesarean delivery outpatient opioid consumption and perception of pain control following implementation of a restrictive opioid prescription protocol. Am J Obstet Gynecol MFM. 2019. PMID: 33345839. doi:10.1016/j.ajogmf.2019.100049

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。